( NYSE:GSK )

News from GSK A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

15 Mar, 2017, 11:13 ET GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration...


06 Mar, 2017, 10:20 ET GSK's MUSCA study shows Nucala® (mepolizumab) significantly improves quality of life and lung function in severe asthma patients with an eosinophilic phenotype

GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic...


19 Jan, 2017, 09:30 ET GSK Announces Winners of 2016 Discovery Fast Track Boston Challenge

GSK has named two academic researchers winners of the 2016 Discovery Fast Track Boston Challenge. The Challenge is sponsored by GSK's Discovery...


21 Nov, 2016, 08:28 ET GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older

GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration's (FDA) Center for Biologics Evaluation and...


16 Nov, 2016, 11:14 ET GSK's Benlysta® (belimumab) Shows Sustained Benefits in Patients with SLE

Results from 7-year Phase III continuation study in US patients GSK today announced results from a 7-year safety and efficacy continuation study...


14 Nov, 2016, 10:28 ET GSK Announces Positive Results in Fourth Consecutive Pivotal Trial of Benlysta® (belimumab) in SLE

Data in Japan, China and South Korea will form basis of new regulatory submissions for Benlysta GSK today announced positive efficacy and...


27 Oct, 2016, 09:11 ET GSK presents new data for shingles candidate vaccine at IDWeek scientific conference

GSK today announced new data for its shingles candidate vaccine Shingrix™, at the Infectious Disease Week (IDWeek) scientific conference in New...


14 Sep, 2016, 17:38 ET GSK's candidate shingles vaccine shows high efficacy against shingles and its complications in adults aged 70 years and over in phase III study published in NEJM

GSK (LSE/NYSE: GSK) today announced the publication of detailed results from a randomised phase III study (ZOE-70) of its investigational shingles...


05 Aug, 2016, 11:00 ET GSK unveils campaign to help prevent meningitis

GSK (LSE: GSK) today launched an educational campaign to help raise awareness of meningitis, a rare but potentially deadly disease. Most teens and...


20 Jul, 2016, 15:51 ET GSK ships 2016-17 seasonal influenza vaccines for US market

 GSK [LSE/NYSE: GSK] announced today it has begun shipping quadrivalent vaccine doses to US healthcare providers, following licensing and...


03 May, 2016, 08:00 ET National survey of uncontrolled asthma patients finds majority mistakenly believe their asthma is under control

 GSK today released data from a new national survey of more than 1,000 uncontrolled asthma patients showing that 67% of adults with...


24 Nov, 2014, 09:00 ET Las familias y la influenza: Lo que necesita saber

La actividad de la influenza, por lo general, aumenta alrededor de noviembre y alcanza el pico entre diciembre y febrero. Hay medidas...


13 Nov, 2014, 15:18 ET Families and Flu: What You Need to Know Now

Flu activity typically increases around November and peaks between December and February.  Simple steps can lower the risks of...


11 Nov, 2014, 10:00 ET GSK Survey Points to Rise of COPD in US

 As patients, caregivers and the healthcare community come together in support of World COPD Day (November 19), a GSK global survey of people...


06 Nov, 2014, 11:37 ET Barriers remain in educating people with diabetes of their increased hepatitis B risk

 Diabetes educators cite a lack of time and competing priorities during counseling sessions with patients as key barriers to educating their...


20 Aug, 2014, 15:33 ET GSK receives FDA approval for Arnuity™ Ellipta® (fluticasone furoate) in the US for the treatment of asthma

GlaxoSmithKline plc today announced that the FDA has approved Arnuity™ Ellipta® (fluticasone furoate inhalation powder), a once-daily...


11 May, 2012, 19:48 ET Stiefel receives US FDA approval of Fabior™ Foam, 0.1%

 Stiefel, a GSK (NYSE: GSK) company, today announced that the US Food and Drug Administration has approved the New Drug Application for Fabior...